Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 2 |
GO:0005684 | U2-type spliceosomal complex | 4 | 2 |
GO:0005686 | U2 snRNP | 5 | 2 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0071011 | precatalytic spliceosome | 4 | 2 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 2 |
GO:0097525 | spliceosomal snRNP complex | 4 | 2 |
GO:0120114 | Sm-like protein family complex | 2 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q1B5
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 2 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 2 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006397 | mRNA processing | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008380 | RNA splicing | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003723 | RNA binding | 4 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.512 |
CLV_PCSK_FUR_1 | 156 | 160 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.607 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.512 |
CLV_PCSK_PC1ET2_1 | 158 | 160 | PF00082 | 0.561 |
CLV_PCSK_PC7_1 | 13 | 19 | PF00082 | 0.509 |
CLV_PCSK_PC7_1 | 156 | 162 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.648 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.440 |
DEG_APCC_DBOX_1 | 17 | 25 | PF00400 | 0.428 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.515 |
DOC_MAPK_DCC_7 | 33 | 42 | PF00069 | 0.407 |
DOC_MAPK_gen_1 | 136 | 144 | PF00069 | 0.516 |
DOC_MAPK_gen_1 | 2 | 10 | PF00069 | 0.453 |
DOC_MAPK_HePTP_8 | 30 | 42 | PF00069 | 0.408 |
DOC_MAPK_MEF2A_6 | 136 | 144 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 33 | 42 | PF00069 | 0.422 |
DOC_WW_Pin1_4 | 52 | 57 | PF00397 | 0.461 |
LIG_14-3-3_CanoR_1 | 141 | 145 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 17 | 25 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 5 | 11 | PF00244 | 0.466 |
LIG_APCC_ABBA_1 | 142 | 147 | PF00400 | 0.472 |
LIG_APCC_ABBAyCdc20_2 | 141 | 147 | PF00400 | 0.475 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.529 |
LIG_LIR_Gen_1 | 85 | 94 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.525 |
LIG_MAD2 | 70 | 78 | PF02301 | 0.375 |
LIG_NRBOX | 20 | 26 | PF00104 | 0.474 |
LIG_NRBOX | 27 | 33 | PF00104 | 0.488 |
LIG_SH2_CRK | 94 | 98 | PF00017 | 0.525 |
LIG_SH2_SRC | 86 | 89 | PF00017 | 0.525 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.525 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.477 |
LIG_SUMO_SIM_anti_2 | 68 | 75 | PF11976 | 0.455 |
LIG_SUMO_SIM_par_1 | 68 | 75 | PF11976 | 0.455 |
LIG_SxIP_EBH_1 | 70 | 83 | PF03271 | 0.375 |
LIG_UBA3_1 | 24 | 33 | PF00899 | 0.418 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.525 |
MOD_CK1_1 | 52 | 58 | PF00069 | 0.552 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.462 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.506 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.525 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.501 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.300 |
MOD_N-GLC_1 | 57 | 62 | PF02516 | 0.513 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.455 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.475 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.408 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.437 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.375 |
MOD_NEK2_2 | 86 | 91 | PF00069 | 0.525 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.462 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.506 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.476 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.517 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.462 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.497 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.456 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.525 |
MOD_ProDKin_1 | 52 | 58 | PF00069 | 0.465 |
MOD_SUMO_rev_2 | 146 | 154 | PF00179 | 0.556 |
TRG_DiLeu_BaEn_1 | 69 | 74 | PF01217 | 0.446 |
TRG_DiLeu_BaLyEn_6 | 35 | 40 | PF01217 | 0.476 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.525 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.487 |
TRG_ER_diArg_1 | 156 | 159 | PF00400 | 0.615 |
TRG_NLS_MonoCore_2 | 156 | 161 | PF00514 | 0.537 |
TRG_NLS_MonoExtC_3 | 156 | 161 | PF00514 | 0.537 |
TRG_NLS_MonoExtN_4 | 156 | 161 | PF00514 | 0.537 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IHF1 | Leishmania donovani | 91% | 100% |
A4HPH0 | Leishmania braziliensis | 86% | 100% |
A4ID92 | Leishmania infantum | 91% | 100% |